In a regulatory filing, Aflac chief actuary and global CRO Albert Riggieri disclosed the sale of 7,649 common shares of the company on August 17 at a price of $76.095 per share.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AFL:
- Hawaiian Electric upgraded, CVS downgraded: Wall Street’s top analyst calls
- Aflac downgraded to Equal Weight from Overweight at Morgan Stanley
- Aflac price target raised to $80 from $70 at Truist
- Early notable gainers among liquid option names on August 2nd
- Aflac price target raised to $86 from $79 at BofA